Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? F Cicchetti, J Drouin-Ouellet, RE Gross Trends in pharmacological sciences 30 (9), 475-483, 2009 | 397 | 2009 |
Cell-based therapies for Parkinson disease—past insights and future potential RA Barker, J Drouin-Ouellet, M Parmar Nature Reviews Neurology 11 (9), 492-503, 2015 | 350 | 2015 |
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling JF Poulin, J Zou, J Drouin-Ouellet, KYA Kim, F Cicchetti, RB Awatramani Cell reports 9 (3), 930-943, 2014 | 311 | 2014 |
Cerebrovascular and blood–brain barrier impairments in Huntington's disease: potential implications for its pathophysiology J Drouin‐Ouellet, SJ Sawiak, G Cisbani, M Lagacé, WL Kuan, ... Annals of neurology 78 (2), 160-177, 2015 | 275 | 2015 |
Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood–brain barrier I St-Amour, I Paré, W Alata, K Coulombe, C Ringuette-Goulet, ... Journal of Cerebral Blood Flow & Metabolism 33 (12), 1983-1992, 2013 | 178 | 2013 |
The role of tau in the pathological process and clinical expression of Huntington’s disease R Vuono, S Winder-Rhodes, R De Silva, G Cisbani, J Drouin-Ouellet, ... Brain 138 (7), 1907-1918, 2015 | 148 | 2015 |
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson’s disease J Drouin-Ouellet, I St-Amour, M Saint-Pierre, J Lamontagne-Proulx, J Kriz, ... International Journal of Neuropsychopharmacology 18 (6), pyu103, 2015 | 145 | 2015 |
REST suppression mediates neural conversion of adult human fibroblasts via microRNA‐dependent and‐independent pathways J Drouin‐Ouellet, S Lau, PL Brattås, D Rylander Ottosson, K Pircs, ... EMBO molecular medicine 9 (8), 1117-1131, 2017 | 106 | 2017 |
Inflammation and neurodegeneration: the story ‘retolled’ J Drouin-Ouellet, F Cicchetti Trends in pharmacological sciences 33 (10), 542-551, 2012 | 93 | 2012 |
Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions J Drouin‐Ouellet, AL Brownell, M Saint‐Pierre, C Fasano, V Emond, ... Glia 59 (2), 188-199, 2011 | 81 | 2011 |
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington’s disease: involvement of astrocyte–neuron interactions F L'episcopo, J Drouin-Ouellet, C Tirolo, A Pulvirenti, R Giugno, N Testa, ... Cell death & disease 7 (4), e2206-e2206, 2016 | 80 | 2016 |
Dopamine and Huntington’s disease LC Schwab, SN Garas, J Drouin-Ouellet, SL Mason, SR Stott, RA Barker Expert review of neurotherapeutics 15 (4), 445-458, 2015 | 69 | 2015 |
Impaired thermoregulation and beneficial effects of thermoneutrality in the 3× Tg-AD model of Alzheimer's disease M Vandal, PJ White, M Tournissac, C Tremblay, I St-Amour, ... Neurobiology of aging 43, 47-57, 2016 | 62 | 2016 |
Direct neuronal reprogramming for disease modeling studies using patient-derived neurons: what have we learned? J Drouin-Ouellet, K Pircs, RA Barker, J Jakobsson, M Parmar Frontiers in Neuroscience 11, 530, 2017 | 61 | 2017 |
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity M Cote, J Drouin-Ouellet, F Cicchetti, D Soulet Brain, behavior, and immunity 25 (6), 1143-1152, 2011 | 54 | 2011 |
The Quebec Parkinson network: a researcher-patient matching platform and multimodal biorepository Z Gan-Or, T Rao, E Leveille, C Degroot, S Chouinard, F Cicchetti, ... Journal of Parkinson's disease 10 (1), 301-313, 2020 | 45 | 2020 |
Cell‐based therapy for Parkinson's disease: A journey through decades toward the light side of the Force M Parmar, O Torper, J Drouin‐Ouellet European Journal of Neuroscience 49 (4), 463-471, 2019 | 42 | 2019 |
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration J Drouin-Ouellet, C Gibrat, M Bousquet, F Calon, J Kriz, F Cicchetti Journal of neuroinflammation 8, 1-12, 2011 | 41 | 2011 |
Simple generation of a high yield culture of induced neurons from human adult skin fibroblasts S Shrigley, K Pircs, RA Barker, M Parmar, J Drouin-Ouellet JoVE (Journal of Visualized Experiments), e56904, 2018 | 32 | 2018 |
Brain repair and reprogramming: the route to clinical translation S Grealish, J Drouin‐Ouellet, M Parmar Journal of Internal Medicine 280 (3), 265-275, 2016 | 30 | 2016 |